title: Clinical significance of cardiac troponins I and T in acute heart failure.
abstract: BACKGROUND
  Elevated cardiac troponin (cTn) levels are relatively common in acute heart failure (AHF).
  
  
  OBJECTIVE
  To evaluate the prevalence and prognostic significance of elevated cTnI and cTnT in AHF.
  
  
  METHODS
  FINN-AKVA is a prospective, multicenter study in AHF. In this analysis, 364 non-ACS patients with measurements of cTnI and cTnT taken on admission and 48 h thereafter were analyzed.
  
  
  RESULTS
  Of the 364 AHF patients, 51.1% had cTnI and 29.7% cTnT levels above the cut-off value. Six-month all-cause mortality was 18.7%. Both cTnI (OR 2.0, 95% CI 1.2-3.5, p=0.01) and cTnT (OR 2.6, 95% CI 1.5-4.4, p=0.0006) were associated with adverse outcome. The mortality risk was proportional to the magnitude of cTn release. On multivariable analysis, Cystatin C (OR 6.3, 95% CI 3.2-13, p<0.0001), logNT-proBNP (OR 1.4, 95% CI 1.0-1.8, p=0.03) and systolic blood pressure on admission (/10 mm Hg increase, OR 0.9, 95% CI 0.8-0.9, p=0.0004) were independent risk markers, whereas the troponins were not significantly associated with increased mortality.
  
  
  CONCLUSIONS
  cTn elevations are frequent in AHF patients without ACS. cTnI is more often elevated than cTnT. Both cTnI and cTnT elevations are associated with increased mortality proportional to the degree elevation but they do not act as independent risk markers.
authors.affiliation: Department of Internal Medicine, Kanta-Hame Central Hospital, Finland. tuomo.ilva@pp.inet.fi
authors.forename: Tuomo
authors.initials: T
authors.lastname: Ilva
authors.forename: Johan
authors.initials: J
authors.lastname: Lassus
authors.forename: Krista
authors.initials: K
authors.lastname: Siirilä-Waris
authors.forename: John
authors.initials: J
authors.lastname: Melin
authors.forename: Keijo
authors.initials: K
authors.lastname: Peuhkurinen
authors.forename: Kari
authors.initials: K
authors.lastname: Pulkki
authors.forename: Markku S
authors.initials: MS
authors.lastname: Nieminen
authors.forename: Harri
authors.initials: H
authors.lastname: Mustonen
authors.forename: Pekka
authors.initials: P
authors.lastname: Porela
authors.forename: Veli-Pekka
authors.initials: VP
authors.lastname: Harjola
mesh_terms: D000368:Aged; D001794:Blood Pressure; D005260:Female; D006333:Heart Failure / Q000378:metabolism*; D006801:Humans; D008297:Male; D009206:Myocardium / Q000737:chemistry*; D011379:Prognosis; D011446:Prospective Studies; D019210:Troponin I / Q000032:analysis*; D020107:Troponin T / Q000032:analysis*
chemical_list: D019210:Troponin I; D020107:Troponin T